Kenji MIZOJIRI
Kenji MIZOJIRI publishes mostly in Molecular Biology, Pharmacology and Pharmacology, on topics such as Drug Transport and Resistance Mechanisms, Retinoids in leukemia and cellular processes and Pharmacogenetics and Drug Metabolism.
- World rank
- #7,551,240 of 7,710,434 ranked researchers
- Rank in Japan
- #364,017 of 383,136
- Works
- 47
- Citations
- 376
- Citations per work
- 8.0
What does Kenji MIZOJIRI research?
Kenji MIZOJIRI's work is mostly in Biochemistry, Genetics and Molecular Biology (19%), Medicine (19%), Pharmacology, Toxicology and Pharmaceutics (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2145.0%
- Life Sciences1429.0%
- Health Sciences919.1%
- Medicine919.1%
- Physical Sciences36.9%
- Chemistry36.9%
- 1Molecular Biology15% of their works
- 2Pharmacology11% of their works
- 3Pharmacology10% of their works
- 4Oncology8% of their works
- 5Organic Chemistry7% of their works
- 6Biochemistry4% of their works
Research topics
- Drug Transport and Resistance Mechanisms
- Retinoids in leukemia and cellular processes
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Antibiotics Pharmacokinetics and Efficacy
- Metabolism and Genetic Disorders
- Receptor Mechanisms and Signaling
- Eicosanoids and Hypertension Pharmacology
Which keywords describe Kenji MIZOJIRI's research?
The keywords of their largest research topics: Nuclear Receptors, ATP-dependent Transporters, Cytochrome P450, Inflammation, Multidrug Resistance, Acute Promyelocytic Leukemia, Antibiotic Pharmacokinetics and Cancer.
- Arachidonic Acid
- G-Protein-Coupled Receptors
- Biochemical Genetics
- Pharmacogenetics
- Cyclooxygenase-2 Inhibitors
- Cancer
- Acute Promyelocytic Leukemia
- Inflammation
- ATP-dependent Transporters
- Nuclear Receptors
- Cytochrome P450
- Multidrug Resistance
- Antibiotic Pharmacokinetics
- Critically Ill Patients
- Drug Metabolism
- Retinoic Acid
- Crystal Structure
- Metabolic Disorders
- Epoxyeicosatrienoic Acids
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Nuclear Receptors162 topics
- ATP-dependent Transporters101 topic
- Cytochrome P450102 topics
- Inflammation102 topics
- Multidrug Resistance101 topic
- Acute Promyelocytic Leukemia61 topic
- Antibiotic Pharmacokinetics61 topic
- Cancer61 topic
- Critically Ill Patients61 topic
- Cyclooxygenase-2 Inhibitors61 topic
- Drug Metabolism61 topic
- Pharmacogenetics61 topic
- Retinoic Acid61 topic
- Biochemical Genetics51 topic
- Crystal Structure51 topic
- G-Protein-Coupled Receptors51 topic
- Metabolic Disorders51 topic
- Arachidonic Acid41 topic
- Epoxyeicosatrienoic Acids41 topic
Where does Kenji MIZOJIRI work?
Kenji MIZOJIRI's main affiliation in the publication record is Futaba (Japan), Japan.
How many publications and citations does Kenji MIZOJIRI have?
OpenAlex counts 47 works and 376 citations for Kenji MIZOJIRI, an h-index of 10, ranking #7,551,240 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kenji MIZOJIRI. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.